Stocks to buy

As I write this, Groundhog’s Day isn’t for another week or so. However, the Federal Reserve certainly seemed to signal that it was business as usual. Bullish investors got about the most dovish statement they could have asked for. This means stocks are likely to head back up. So why write about mutual funds? Well
0 Comments
The plant-based boom is just starting to sprout. In fact, with millions of people turning to plant based diets, analysts at Credit Suisse say the industry could grow 100-fold to $1.4 trillion by 2050, as noted by VegNews’ contributor Anna Starostinetskaya. Shorter-term, Bloomberg Intelligence says the plant-based industry could balloon to $162 billion by 2030
0 Comments
Teladoc Health (NYSE:TDOC) is among the pandemic-driven high-fliers on a sustained downtrend. At the height of the lockdown, investors piled into companies that would thrive in a stay-at-home and work-at-home scenario. In one year’s time, shares of the virtual healthcare services company rocketed 175% to a high of $308, made in February 2021. Source: fizkes/ShutterStock.com
0 Comments
I have been a big Nvidia (NASDAQ:NVDA) bull for a long time now. All you have to do is look at a chart of NVDA stock over the past five years to see why. The company continues to dominate competitors and there is seemingly nothing to slow it down.  Source: rafapress / Shutterstock.com When NVDA
0 Comments
Known as a silicon-wafer fabricator or “fab,” Taiwan Semiconductor (NYSE:TSM) struggled along with other tech part makers amid 2021’s global supply shortage. Consequently, TSM stock chopped around and made little progress that year. Source: Sundry Photography / Shutterstock.com Now however, Wall Street is warming up to Taiwan Semiconductor in 2022. This company is rarely buzz-worthy in
0 Comments
When Tilray (NASDAQ:TLRY) posted a small profit in the last quarter, it marked a positive turning point. Skittish investors will ignore TLRY stock because of its meme trade last year sending it to a $67 high. Source: Ralf Liebhold / Shutterstock.com Those who avoided the quick pump (momentum buying) and fast dump (panic selling) should
0 Comments
Novavax (NASDAQ:NVAX) stock has been an under-performer among stocks that have been in the Covid-19 vaccine race. After touching highs of $331.7 in February 2021, NVAX stock has plunged to its current price levels of $90. Source: Vladimka production / Shutterstock.com Of course, there have been fundamental factors that have served as catalysts for the
0 Comments
ChargePoint (NYSE:CHPT) is currently trading at low levels, yes. But it isn’t trading at those levels due to any particular fundamental weakness. In fact, I’d argue that purchasing CHPT stock right now is a great opportunity. Source: YuniqueB / Shutterstock.com True, the market has softened on electric vehicle (EV) stocks. These picks aren’t quite as hot
0 Comments